Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference58 articles.
1. Hepatocellular carcinoma;Forner;Lancet,2012
2. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10.;Ferlay,2010
3. The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease;Krag;Gut,2012
4. Reduced mortality with non-selective betablockers compared to banding is not related to prevention of bleeding or bleeding related mortality: systematic review of randomized trials;Krag;J Hepatol,2011
5. Beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis;Senzolo;Liver Int,2009
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impacts of gut microbiota alteration on age-related chronic liver diseases;Digestive and Liver Disease;2024-01
2. Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study;Frontiers in Medicine;2021-09-23
3. Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States;Alimentary Pharmacology & Therapeutics;2021-07-05
4. β-blockers in advanced cirrhosis: More friend than enemy;Clinical and Molecular Hepatology;2021-07-01
5. Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice;Journal for ImmunoTherapy of Cancer;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3